Tag: #Global Trends

Project Specifications and Capital Investment According to a regulatory application filed with state authorities, Bristol Myers Squibb (BMS) is weighing... Read more

Origin and Core of the Contract Dispute Swiss pharmaceutical giant Novartis has unilaterally terminated a plant leasing contract with the... Read more

Regulatory Approval and Market Expectations AstraZeneca has announced that its new oral hypertension therapy, branded as Baxfendy (baxdrostat), has been... Read more

Regulatory Milestone and Indications The US Food and Drug Administration (FDA) has granted clearance for the 11th U.S. indication of... Read more

Transaction and Licensing Agreement Boehringer Ingelheim has entered into a global licensing agreement with Massachusetts-based Immunitas Therapeutics to acquire the... Read more

Expansion Into Curative-Intent Treatment Settings The US Food and Drug Administration (FDA) has granted regulatory clearance for two new indications... Read more

Indian pharmaceutical giant Sun Pharma has initiated a voluntary recall of a single lot of Doxorubicin hydrochloride liposome injection in... Read more

Product Launch Overview The joint venture between Dr. Reddy’s Laboratories and Nestlé India has launched Celevida GLP Plus in the... Read more

IQVIA and Kexing Biopharm have announced an expansion of their strategic collaboration to support a global, multi-product biosimilar development and... Read more